Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGINTERVENTIONAL

Attention Deficit Hyperactivity Disorder

Addictions and Attention Deficit Disorder With or Without Hyperactivity

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

The ADA cohort aims for the systematic and standardized collection of sociodemographic, clinical and neuropsychological data, during 2 visits (inclusion and 12 months), from patients suffering from the co-occurrence of ADHD (Attention Deficit Hyperactivity Disorder) and addiction(s), in addition to the treatment as usual adapted to each situation.

Who May Be Eligible (Plain English)

Inclusion Criteria : - Patients aged over 15 years and 3 months - For whom a diagnosis of ADHD has been confirmed less than 6 weeks ago - For whom the diagnosis of one or more addictive disorder(s) (substance use disorder or behavioral addiction) has been confirmed - Meeting the indication for treatment with MPH according to European recommendations (Kooij et al., 2019) - For patients who can actually benefit from MPH: who have not yet started taking MPH - Social security affiliates Exclusion Criteria : - Presenting disorders of higher cognitive functions (at the discretion of the referring clinician or the investigator making the inclusion), making data collection impossible - Presenting difficulties in reading or writing the French language making data collection impossible - Unable to commit to being available for the 2 visits planned as part of the cohort - Under guardianship or legal protection Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria : * Patients aged over 15 years and 3 months * For whom a diagnosis of ADHD has been confirmed less than 6 weeks ago * For whom the diagnosis of one or more addictive disorder(s) (substance use disorder or behavioral addiction) has been confirmed * Meeting the indication for treatment with MPH according to European recommendations (Kooij et al., 2019) * For patients who can actually benefit from MPH: who have not yet started taking MPH * Social security affiliates Exclusion Criteria : * Presenting disorders of higher cognitive functions (at the discretion of the referring clinician or the investigator making the inclusion), making data collection impossible * Presenting difficulties in reading or writing the French language making data collection impossible * Unable to commit to being available for the 2 visits planned as part of the cohort * Under guardianship or legal protection

Treatments Being Tested

OTHER

Patients suffering from the co-occurrence of ADHD and addiction(s)

All eligible patients over 15 years and 3 months (age limit between child psychiatry and adult psychiatry), presenting both a diagnosis of ADHD and a diagnosis of at least one addictive disorder (SUD, AUD (Alcohol Use Disorder) and/ or behavioral addiction), starting care in one of the three participating centers, and meeting the indication for treatment with MPH according to European recommendations (J. J. S. Kooij et al., 2019)

Locations (3)

Nantes University Hospital
Nantes, Loire-Atlantique, France
CHRU de Brest
Brest, France
CHRU de Tours
Tours, France